Lincoln National Corp’s T2 Biosystems, Inc TTOO Stock Holding History

Lincoln National Corp’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	-$14K	–	781
2020 Q3	$14K	Buy	+2	New	+$14.8K	﹤0.01%	677

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lincoln National Corp's TTOO Position: Q4 2020 in Review

Lincoln National Corp sold out of T2 Biosystems, Inc (TTOO) in Q4 2020, closing a stake of 2 shares — an estimated $14K sold.

Lincoln National Corp first reported a position in TTOO in Q3 2020 and held it in 1 quarter. The position peaked at $14K in Q3 2020. 62 funds tracked by Wall St. Rank hold TTOO as of Q4 2020.

Lincoln National Corp reported no remaining T2 Biosystems, Inc position as of Q4 2020 after selling out during the quarter.
Lincoln National Corp sold 2 T2 Biosystems, Inc shares in Q4 2020, an estimated $14K.
Lincoln National Corp first reported a position in T2 Biosystems, Inc in Q3 2020 and held it in 1 quarter.
Lincoln National Corp's T2 Biosystems, Inc position peaked at $14K in Q3 2020.
62 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2020.

Based on Lincoln National Corp's 13F filing for Q4 2020, filed 5 Feb 2021.